Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

JG-98 is an inhibitor of the protein-protein interaction between Hsp70 and Bcl-2-associated athanogene 3 (BAG-3; IC50 = 1.6 µM) that binds to an allosteric site on Hsp70.1 JG-98 selectively inhibits the proliferation of a variety of cancer cells, including MDA-MB-231 and MCF-7 breast cancer cells, over mouse embryonic fibroblasts (MEFs; EC50s = 0.39, 0.71, and 4.5 µM, respectively). It also reduces aerobic respiration and the mitochondrial membrane potential in 22Rv1 castration-resistant prostate cancer cells and sensitizes 22Rv1 cells to the androgen receptor pathway inhibitors (ARPIs) enzalutamide (Item No. 11596) and abiraterone (Item No. 9002768).2 JG-98 (3 mg/kg every two days) reduces tumor growth in MCF-7 breast cancer and HeLa cervical cancer mouse xenograft models.1
WARNING This product is not for human or veterinary use.
1. Validation of the Hsp70-
2. Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-